OSCR Instantâneo da Ação Preço, capitalização de mercado, P/E, EPS, ROE, dívida/patrimônio, intervalo de 52 semanas

03
Preço $30.94
P/E (TTM) 21.3
EPS (TTM) $1.45
Receita (TTM) $15.32B
ROE (TTM) 34.3%
Dívida/Capital (MRQ) 0.2
Intervalo 52 Semanas $11–$34

OSCR Gráfico de Preço da Ação OHLCV diário com indicadores técnicos — panorâmica, zoom e personalize sua visualização

04
intervalo
barras

A granularidade da barra se adapta ao período selecionado — passe o mouse sobre o gráfico para ver a abertura/máxima/mínima/fechamento de uma barra.

Sobre Oscar Health, Inc. Class A Common Stock Visão geral da empresa da Wikipedia

05 · wikidata

Oscar Management Corporation, doing business as Oscar Health is an American for-profit health insurance company, founded in 2012 by Joshua Kushner, Kevin Nazemi and Mario Schlosser, and is headquartered in New York City. The company sells health insurance and additionally provides other services in the health insurance industry through telemedicine, healthcare focused technological interfaces, and transparent claims pricing systems.

History

2012–2015

According to the company, it was founded in 2012 by Mario Schlosser, Joshua Kushner, and Kevin Nazemi, who were classmates at Harvard Business School. Mother Jones reported in March 2020 that Kushner and his brother, Jared, owned the firm's parent company, Thrive Partners III, at the time of its incorporation in 2013. Oscar began selling insurance for 2013, the same year that the Affordable Care Act exchanges and individual mandate went into effect for the 2014 plan year. In its first year, Oscar secured 16,000 members. In 2015, Oscar expanded coverage to New Jersey and grew to about 40,000 members.

2016

Oscar had 145,000 members in New York, New Jersey, California, and Texas in 2016. The firm expanded its operations to Tempe, Arizona, in August that year, where it decided to locate its Concierge teams, their name for their member services model. On August 23, Oscar announced it would be exiting the New Jersey Marketplace at the end of 2016, citing uncertainties in the market that would make it challenging "to operate effectively and continue to deliver access to quality healthcare." Oscar also announced that it would halve the size of its provider network in New York amidst rising premiums in order to "gain more control over pricing and patient experience".

In November 2016, the firm opened the Oscar Center in partnership with Mount Sinai Health System. Located in Brooklyn Heights, next to the Jay Street–MetroTech station, the Oscar Center had a primary care practice only available to Oscar policyholders, with a doctor, nurse practitioner, and a behavioral health specialist. It also hosted free classes for members, such as yoga classes or classes for expectant mothers. On March 13, 2020, Oscar closed the Oscar Center "until further notice."

2017

On April 25, 2017, Oscar announced its entrance into the small group insurance market, offering health plans in New York. On June 15, 2017, Oscar announced its partnership with Cleveland Clinic to offer individual health insurance plans to consumers in five counties in Northeastern Ohio.

On June 21, 2017, Oscar announced its intention to expand to additional markets in 2018 in areas of Tennessee, Ohio, Texas, New Jersey and California. On July 12, 2017, Oscar announced that it would be selling small group insurance in the Nashville metro area to companies with up to 50 employees through a strategic partnership with Humana.

A report by the New York Times in October 2017 speculated that Oscar Health had ties to Saudi Arabia. That month, Jared and Joshua Kushner visited Saudi Arabia's Crown Prince Mohammed bin Salman within days of each other. Despite Jared severing ties with Thrive Partners when he began working for the Trump administration, these coordinated visits raised questions about his ability to be impartial on Saudi affairs. Five months after Kushner's visit to Saudi Arabia in October 2017, Oscar Health announced a $165 million round of financing.

While a spokesman for Kushner said that Oscar Health's management didn't know of direct investment by the Saudis, he declined to disclose if Saudis had invested in Thrive funds. He only confirmed that Thrive hadn't received money from any Saudi parties since the presidential election. In May 2018, Jared Kushner disclosed $8.2 million in capital gains from Thrive funds.

2020–present

In January 2020, Oscar announced a partnership with Cigna to bring health insurance plans to small businesses. The partnership, Cigna + Oscar, will "launch in select markets in 2020 and plan to expand the partnership over time."

As of June 2020, Oscar had sold individual health insurance plans, both directly and through health insurance marketplaces, in New York, Texas and California. Oscar sells Medicare Advantage plans in New York City and Houston, Texas. Mario Schlosser is the company's CEO, after serving as Co-CEO with Nazemi until the latter's departure in early 2015. While Kushner does not hold a formal role in Oscar's daily operations, he remains a major shareholder and Schlosser confirmed (as of 2017) that he has "significant input in multiple aspects of the company like strategy, hiring, and marketing."

Oscar Health raised $1.2 billion on March 3, 2021, after an IPO.

Oscar Health reported 1.1 million members across its platform, which equates to 1 in 13 ACA exchange-based enrollees. The company announced it would exit the Arkansas and Colorado markets for plan year 2023.

Mario Schlosser steps down as CEO on April 3, 2023, transitioning to President of Technology. Mark Bertolini takes over as CEO.

In 2025, Oscar Health was ranked 437th by revenue on the Fortune 500 list and 42nd within the healthcare sector in the same rankings.

Marketing and brand

Oscar Health has run marketing campaigns on the New York City Subway. Bloomberg News reported the advertising campaigns feature cartoons suggesting "an easier way of getting medical care." AdWeek described Oscar Health's print ads as featuring "whimsical, animated characters".

In 2015, AdWeek reported that Oscar was airing its first television campaign targeted at the demographics of "new parents who are too frazzled to shop for health insurance." The ad launched on network stations in New Jersey and New York areas, cable, movie theaters located in New Jersey and in advertising within the Spotify app.

In 2016, Oscar ran a subway ad campaign with an educational bent around what the problems are with the American healthcare system.

Finances

Funding

Oscar has raised capital through a series of funding rounds. Its investors include Thrive Capital, General Catalyst Partners, Khosla Ventures, CapitalG, and Fidelity Investments.

During the May 2014 Series A round, Peter Thiel's Founders Fund led the series investing $30 million. By the close of Series A, Forbes reported the valuation of the company at $800 million.

During the 2015 Series B round, Oscar Health raised $145 million, bringing the total capital raised to $300 million, thus valuing the company at $1.5 billion. Series B investors included Formation 8, Horizons Ventures, Wellington Management Company, and Goldman Sachs.

In September 2015, Oscar announced a funding round with Google Ventures and Google Capital, valuing the company at $1.75 billion.

During the 2016 Series C round, Oscar raised $400 million led by Fidelity Investments, with secondary participation from previous investors, with a reported valuation of $2.7 billion. In 2018, Alphabet invested $375 million in Oscar Health. As of 2019, the company had raised $1.3 billion, and was valued at $3.2 billion.

In June 2020, Oscar raised $225 million in funding, in which the funding round saw participation from previous investors and also new investors, namely Baillie Gifford and Coatue.

Revenue

In 2014, New York magazine reported that as of May 2014, Oscar Health had 16,000 subscribers enrolled in its insurance program producing an estimated $72 million. In 2015, Forbes reported that Oscar Health had 40,000 subscribers with an average subscriber paying annual fees of $4,500, placing Oscar Health's revenue estimates at $180 million.

Vox reported that in 2015, Oscar Health lost $92.4 million in New York as the firm's analytical models failed to accurately forecast "the people who signed up for coverage were sicker than the company had expected."

By 2016, Oscar Health had 135,000 subscribers, with roughly half residing in New York State.

In February 2017, Bloomberg reported that Oscar had lost $204.9 million in 2016.

In May 2017, Bloomberg reported that Oscar's first quarter loss had narrowed by nearly half, writing that the company was "beginning to get a handle on its medical costs." In August 2017, Bloomberg also reported that Oscar had posted a $57.6 million loss in the first half of 2017, down from the $83 million lost posted the year prior.

In December 2017, TechCrunch reported that Oscar would expect to generate $1 billion in revenue and enroll 250,000 in 2018.

In January 2020, TechCrunch reported that Oscar served 400,000 members and expected to bring in $2 billion by the end of the year.

Headquarters and offices

Oscar's headquarters are located in Tribeca, New York City. They also have a technology outpost in Los Angeles and a member services operation in Tempe, Arizona.

Fonte: Wikipedia (Inglês), CC BY-SA 4.0 · Ver na Wikipedia ↗

Wikidata ↗

setorFinancials indústriaInsurance funcionários2.305 paísUS

Desempenho de 10 Anos Tendências de receita, lucro líquido, margens e EPS

06
Receita$11.70B
2019-12-31 → 2025-12-31
EPS$-1.69
2019-12-31 → 2025-12-31
Fluxo de caixa livre$1.06B
2021-12-31 → 2025-12-31
Margem líquida3.6%
2021-12-31 → 2025-12-31
Avaliação e Proporções 07–12

Avaliação Rácios P/E, P/S, P/B, EV/EBITDA — a ação está cara ou barata?

Métrica Tendência de 5 anos OSCR média 5A Mediana de Pares Veredito
P/E (TTM) 21.3média 5A ≈23.0 ≈23.0 15.4 Sobreavaliado

A mediana dos pares é calculada em uma base padronizada por métrica e pode não corresponder sempre à base TTM/MRQ mostrada para esta ação.

valor · ≈ média 5A · mediana do setor · veredicto relativo à mediana

Histórico de Lucros EPS real vs. estimativa, surpresa %, taxa de acerto, próxima data de resultados

14
Surpresa Média 24.3%
Próximo relatório Nov 04, 2026
PeríodoRelatórioEPS ActualEPS est.Surpresa
30 de Junho de 2026 Ago 6, 2026 $1.10 $0.39 179.5%
31 de Março de 2026 $2.07 $1.21 71.5%
31 de Dezembro de 2025 $-1.24 $-0.91 -37.0%
30 de Setembro de 2025 $-0.53 $-0.57 6.6%
30 de Junho de 2025 $-0.89 $-0.47 -88.5%
31 de Março de 2025 $0.92 $0.81 13.8%

Fundamentos Completos Todas as métricas por ano — demonstração de resultados, balanço patrimonial, fluxo de caixa

15
Demonstração de Resultados 13
Métrica Tendência 202520242023202220212020
Revenue $11.70B$9.18B$5.86B$3.96B$1.84B$463M
SG&A Expense $2.05B$1.76B$1.43B$1.26B$265M$167M
Operating Income $-396M$57M$-236M$-590M$-544M$-402M
Interest Expense ··$25M$23M$5M$4M
Other Non-op $-23M$-105.0K$-7M$2M$-1M·
Pretax Income $-437M$33M$-267M$-610M$-571M$-406M
Income Tax $6M$7M$3M$-523.0K$846.0K$1M
Net Income $-443M$25M$-271M$-606M$-573M$-407M
EPS (Basic) $-1.69$0.11$-1.22$-2.85$-3.20$-14.16
EPS (Diluted) $-1.69$0.10$-1.22$-2.85$-3.20$-14.16
Shares (Basic) 262,388,000240,386,000221,655,000212,475,000178,967,05629,263,424
Shares (Diluted) 262,388,000265,853,000221,655,000212,475,000178,967,05629,263,424
EBITDA $-367M$89M$-205M·$-530M·
Balanço Patrimonial 23
Métrica Tendência 202520242023202220212020
Cash & Equivalents $2.77B$1.53B$1.87B$1.56B$1.10B$826M
Short-term Investments ·$624M$690M···
Receivables $363M·····
Other Current Assets $24M$21M$7M$6M$4M·
Current Assets $4.61B$2.85B$3.06B$4.12B$2.31B$1.87B
PP&E (Net) $88M$67M$62M$60M$47M$36M
PP&E (Gross) $230M$181M$150M$117M$89M$63M
Accum. Depreciation $142M$114M$88M$57M$42M$27M
Other Non-current Assets $120M$82M$83M$95M$97M$13M
Total Assets $6.33B$4.84B$3.60B$4.53B$3.32B$2.27B
Accounts Payable $507M$432M$273M$298M$235M$138M
Current Liabilities $4.86B$3.46B$2.43B$3.26B$1.85B$1.67B
Capital Leases $52M$61M$67M$72M$77M·
Other Non-current Liabilities $52M$61M$68M$72M$77M$0
Total Liabilities $5.34B$3.82B$2.80B$3.63B$1.93B$1.82B
Total Debt $430M$300M$299M·$0·
Common Stock ·····$2.0K
Paid-in Capital $4.26B$3.87B$3.68B$3.51B$3.39B$133M
Retained Earnings $-3.29B$-2.85B$-2.88B$-2.61B$-2.00B$-1.43B
Treasury Stock $3M$3M$3M$3M$3M$3M
AOCI $18M$-2M$1M$-10M$-4M$879.0K
Stockholders' Equity $978M$1.01B$804M$890M$1.39B$-1.30B
Liabilities + Equity $6.33B$4.84B$3.60B$4.53B$3.32B$2.27B
Fluxo de Caixa 16
Métrica Tendência 202520242023202220212020
D&A $29M$32M$31M$15M$15M$11M
Stock-based Comp $88M$110M$160M$112M$86M$36M
Deferred Tax $2M$-2M$58.0K$-165.0K$-101.0K$-67.0K
Other Non-cash $1.42B$813M$-192M·$290M·
Operating Cash Flow $1.09B$978M$-272M$380M$-182M$223M
CapEx $36M$28M$26M$29M$26M$14M
Investing Cash Flow $-241M$-1.39B$577M$-227M$-775M$-345M
Debt Issued $410M$0$0$305M$0$147M
Net Debt Issued $410M$0$0···
Stock Repurchased ····$0$0
Net Stock Activity ····$0·
Financing Cash Flow $399M$68M$6M$301M$1.24B$612M
Net Change in Cash $1.25B$-341M$311M$455M$282M$490M
Taxes Paid $18M$674.0K$2M$2M$697.0K$2M
Free Cash Flow $1.06B$950M$-298M·$-208M·
Levered FCF ··$-323M·$-212M·
Lucratividade 7
Métrica Tendência 202520242023202220212020
Operating Margin -3.4%0.62%-4.0%·-29.6%·
Net Margin -3.8%0.28%-4.6%·-31.1%·
Pretax Margin -3.7%0.36%-4.6%·-31.0%·
EBITDA Margin -3.1%0.97%-3.5%·-28.8%·
ROA -7.9%0.60%-6.7%·-20.5%·
ROE -44.5%2.8%-32.0%·-36.7%·
ROIC -28.5%3.4%-21.6%·-39.3%·
Liquidez e Solvência 5
Métrica Tendência 202520242023202220212020
Current Ratio 0.90.81.3·1.2·
Quick Ratio 0.60.60.8·0.6·
Debt / Equity 0.40.30.4·0.0·
LT Debt / Equity 0.40.30.4·0.0·
Interest Coverage ··-9.6·-115.4·
Eficiência 1
Métrica Tendência 202520242023202220212020
Asset Turnover 2.12.21.4·0.7·
Por Ação 3
Métrica Tendência 202520242023202220212020
Revenue / Share $44.60$34.52$26.45·$10.27·
Cash Flow / Share $4.17$3.68$-1.23·$-1.02·
EPS (TTM) $-1.69$0.10$-1.22$-2.85$-3.20·
Taxas de Crescimento 3
Métrica Tendência 202520242023202220212020
Revenue YoY 27.5%56.5%47.9%115.6%297.3%·
Revenue CAGR 3Y 43.5%70.9%133.1%···
Revenue CAGR 5Y 90.8%·····
Avaliação (TTM) 4
Métrica Tendência 202520242023202220212020
Revenue TTM $11.70B$9.18B$5.86B$3.96B$1.84B·
Net Income TTM $-443M$25M$-271M$-606M$-573M·
P/E -8.5134.4-7.5-0.9-2.5·
Earnings Yield -11.8%0.74%-13.3%-115.9%-40.8%·

Período mais recente à esquerda · valores nulos mostrados como ·

Demonstrações Financeiras Demonstração de resultados, balanço patrimonial, fluxo de caixa — anual, últimos 5 anos

16
Métrica 2025-12-312024-12-312023-12-312022-12-312021-12-31
Receita $11.70B $9.18B $5.86B $3.96B $1.84B
Margem Operacional % -3.4% 0.62% -4.0% · -29.6%
Lucro líquido $-443M $25M $-271M $-606M $-573M
EPS Diluído $-1.69 $0.10 $-1.22 $-2.85 $-3.20

Investidores institucionais (13F) 459 declarantes · $6.2B total · Em 30 de Setembro de 2026

17

Instituições que relatam a posse desta ação em seu Formulário 13F trimestral da SEC. Apenas posições compradas; um único declarante pode aparecer duas vezes para opções separadas. Grandes posições de compra/venda compensatórias geralmente refletem market-making ou inventário protegido, não convicção direcional.

Detentores 459
Valor detido $6.2B
Novas posições 125
Posições encerradas 46
Atividade institucional — Q2 2026 vs trimestre anterior
Novas posições Posições encerradas Aumentou Diminuído Variação líquida de ações
125 (+51 vs trimestre anterior) 46 (-18 vs trimestre anterior) 147 (+22 vs trimestre anterior) 115 (+3 vs trimestre anterior) +22.8M

Comparado a Q1 2026. Os registros do Formulário 13F da SEC devem ser feitos em até 45 dias após o final do trimestre, mais um pequeno período de tolerância para registrantes atrasados — trimestres ainda dentro desse período são ignorados em favor do par mais recente totalmente reportado.

Instituição Valor Ações % de 13F rastreado Tipo
BlackRock, Inc. $587.153.449 20.587.428 9,50% Ações
D. E. Shaw & Co., Inc. $360.595.957 12.643.617 5,84% Ações
VANGUARD PORTFOLIO MANAGEMENT LLC $314.559.172 11.029.424 5,09% Ações
VANGUARD CAPITAL MANAGEMENT LLC $301.725.543 10.579.437 4,88% Ações
VANGUARD GROUP INC $297.476.962 20.701.250 4,82% Ações
AMERICAN CENTURY COMPANIES INC $258.255.502 9.055.242 4,18% Ações
JANE STREET GROUP, LLC $181.530.912 6.365.039 2,94% Ações
Thrive Capital Management, LLC $180.919.957 6.343.617 2,93% Ações
GEODE CAPITAL MANAGEMENT, LLC $165.994.311 5.819.186 2,69% Ações
STATE STREET CORP $165.454.531 5.801.351 2,68% Ações
SUSQUEHANNA INTERNATIONAL GROUP, LLP $162.917.648 5.712.400 2,64% Opção de compra
FMR LLC $142.557.861 4.998.523 2,31% Ações
CITADEL ADVISORS LLC $120.626.823 4.229.552 1,95% Ações
TWO SIGMA INVESTMENTS, LP $115.097.850 4.035.689 1,86% Ações
DIMENSIONAL FUND ADVISORS LP $101.885.043 3.571.731 1,65% Ações
BIT Capital GmbH $97.480.134 3.417.957 1,58% Ações
RENAISSANCE TECHNOLOGIES LLC $93.673.940 3.284.500 1,52% Ações
JACOBS LEVY EQUITY MANAGEMENT, INC $86.282.012 3.025.316 1,40% Ações
GLYNN CAPITAL MANAGEMENT LLC $73.462.615 2.575.828 1,19% Ações
CITADEL ADVISORS LLC $72.469.320 2.541.000 1,17% Opção de compra
GOLDMAN SACHS GROUP INC $65.298.165 2.289.557 1,06% Ações
NORTHERN TRUST CORP $63.063.680 2.211.209 1,02% Ações
WOLVERINE ASSET MANAGEMENT LLC $61.825.656 2.167.800 1,00% Opção de venda
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $60.458.493 2.119.863 0,98% Ações
MORGAN STANLEY $60.299.272 2.114.280 0,98% Ações
SUSQUEHANNA INTERNATIONAL GROUP, LLP $55.351.616 1.940.800 0,90% Opção de venda
JANE STREET GROUP, LLC $53.968.396 1.892.300 0,87% Opção de compra
Nuveen, LLC $50.501.648 1.770.745 0,82% Ações
BlackBarn Capital Partners LP $49.910.000 1.750.000 0,81% Opção de venda
BNP PARIBAS FINANCIAL MARKETS $48.660.710 1.706.196 0,79% Ações
VANGUARD FIDUCIARY TRUST CO $45.996.029 1.612.764 0,74% Ações
CITADEL ADVISORS LLC $44.459.828 1.558.900 0,72% Opção de venda
STATE OF MICHIGAN RETIREMENT SYSTEM $41.354.000 1.450.000 0,67% Ações
BANK OF AMERICA CORP /DE/ $37.594.294 1.318.173 0,61% Ações
Assenagon Asset Management S.A. $35.592.732 1.247.992 0,58% Ações
TWO SIGMA ADVISERS, LP $35.534.136 2.472.800 0,58% Ações
UBS Group AG $34.596.357 1.213.056 0,56% Ações
JANE STREET GROUP, LLC $33.796.200 1.185.000 0,55% Opção de venda
GROUP ONE TRADING LLC $32.744.154 1.148.112 0,53% Ações
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND $31.200.652 1.093.992 0,51% Ações
Qube Research & Technologies Ltd $30.913.940 1.083.939 0,50% Ações
TUDOR INVESTMENT CORP ET AL $29.055.948 1.018.792 0,47% Ações
GILDER GAGNON HOWE & CO LLC $28.576.515 1.001.982 0,46% Ações
JPMORGAN CHASE & CO $26.387.407 885.558 0,43% Ações
FEDERATED HERMES, INC. $26.096.200 915.014 0,42% Ações
WELLS FARGO & COMPANY/MN $23.408.907 820.789 0,38% Ações
Walleye Capital LLC $23.243.058 814.974 0,38% Ações
Point72 Asset Management, L.P. $22.809.212 799.762 0,37% Ações
Walleye Trading LLC $22.744.700 797.500 0,37% Opção de compra
Bank of New York Mellon Corp $22.032.138 772.515 0,36% Ações

Mostrar todos os 459 proprietários institucionais →

Ativistas e proprietários de 5%+ 2 participações

18

Investidores que apresentaram o Schedule 13D da SEC — propriedade benéfica acima de 5% com a intenção de influenciar o emissor (participações ativistas, campanhas no conselho, M&A). Cada linha mostra o estado mais recente conhecido da posição desse declarante.

Declarante Declarado Participação Status Propósito Declaração
Claremount TW, L.P., Claremount V Associates, L.P., Claremount VI Associates, L.P., Claremount VII Associates, L.P., Joshua Kushner, Thrive Capital Partners II, L.P., Thrive Capital Partners III, L.P., Thrive Capital Partners V, L.P., Thrive Capital Partners VI Growth, L.P., Thrive Capital Partners VII Growth, L.P., Thrive Partners II GP, LLC, Thrive Partners III GP, LLC, Thrive Partners V GP, LLC, Thrive Partners VI GP, LLC, Thrive Partners VII GP, LLC, Thrive Partners VII Growth GP, LLC 18 de Setembro de 2026 12,10% Emenda · SEC
Thrive Capital Partners II, L.P. (2), Thrive Partners II GP, LLC (2), Thrive Capital Partners III, L.P. (2), Claremount TW, L.P. (2), Thrive Partners III GP, LLC (2), Thrive Capital Partners V, L.P. (2), Claremount V Associates, L.P. (2), Thrive Partners V GP, LLC (2), Thrive Capital Partners VI Growth, L.P. (2), Claremount VI Associates, L.P. (2), Thrive Partners VI GP, LLC (2), Thrive Capital Partners VII Growth, L.P. (2), Thrive Partners VII Growth GP, LLC (2), Claremount VII Associates, L.P. (2), Thrive Partners VII GP, LLC (2), Joshua Kushner (2) ×4 declarações 13 de Novembro de 2024 · Declaração inicial · SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Executivos da empresa 23 insiders · 12 diretores · 12 conselheiros

19
Investidor com informação privilegiada Função Última atividade Ações detidas Compras 12m Vendas 12m Líquido 12m
Mark T Bertolini Chief Executive Officer 30 de Junho de 2026 S 7.751.570 1 8 $-58.759.399
Richard Scott Blackley Chief Financial Officer 3 de Setembro de 2026 S 1.046.108 0 9 $-7.941.907
Janet Liang President, Oscar Insurance 3 de Setembro de 2026 S 248.697 0 5 $-821.072
Steven Wolin Chief Operating Officer 1 de Dezembro de 2024 M 102.598 0 0 $0
Meghan V. Joyce Chief Operating Officer 1 de Março de 2022 M 43.070 0 0 $0
Joshua Kushner Co-Founder and Vice Chairman 18 de Setembro de 2026 J 0 0 0 $0
Victoria Baltrus Chief Accounting Officer 3 de Setembro de 2026 S 213.631 0 5 $-194.480
Adam Mcananey Chief Legal Officer 3 de Setembro de 2026 S 209.004 0 5 $-783.513
Alessandrea C. Quane EVP, Chief Insurance Officer 5 de Dezembro de 2024 M 430.216 0 0 $0
Ranmali Bopitiya EVP & Chief Legal Officer 1 de Dezembro de 2024 M 241.488 0 0 $0
Dennis Weaver Chief Clinical Officer 1 de Dezembro de 2022 M 27.110 0 0 $0
Joel Klein Chief Policy & Strat. Officer 18 de Agosto de 2021 M 17 0 0 $0
Vanessa Ames Wittman Conselheiro 18 de Setembro de 2026 S 112.121 0 1 $-806.000
Mario Schlosser Conselheiro 3 de Setembro de 2026 S 449.444 0 29 $-68.790.950
William Gassen Conselheiro 9 de Julho de 2026 A 82.840 0 0 $0
David Plouffe Conselheiro 9 de Julho de 2026 A 137.121 0 0 $0
Sid Sankaran Conselheiro 9 de Julho de 2026 A 22.609 0 0 $0
Laura W Lang Conselheiro 4 de Junho de 2026 A 82.840 0 0 $0
Jeffery H Boyd Conselheiro 9 de Abril de 2026 A 705.673 0 0 $0
Elbert O. Robinson Jr. Conselheiro 12 de Maio de 2025 S 64.512 0 0 $0
Jr Charles E Phillips Conselheiro 14 de Outubro de 2022 A 85.787 0 0 $0
Teri List-Stoll Conselheiro 5 de Março de 2021 A 50.000 0 0 $0
Ari Fischel · 5 de Março de 2021 A 0 0 0 $0

Executivos de declarações SEC Formulário 3/4/5; líquido = apenas P/V de mercado aberto

Participação em ETFs Detido por 46 ETFs

20

O peso reflete apenas participações diretas em ações (N-PORT); fundos alavancados ou baseados em derivativos podem deter exposição adicional a swaps não mostrada.

Fundo Peso Unidades Em Fonte
ABLS · Abacus FCF ETF Trust 5,83% 867 NS 31 de Julho de 2026 N-PORT
PTH · Invesco Exchange-Traded Fund Trust 1,95% 188.213 SH 2 de Outubro de 2026 Diário
RNIN · EA Series Trust 1,20% 70.047 NS 31 de Julho de 2026 N-PORT
FYC · First Trust Exchange-Traded AlphaDE… 0,74% 307.696 NS 31 de Julho de 2026 N-PORT
JSML · Janus Detroit Street Trust 0,60% 69.666 NS 31 de Julho de 2026 N-PORT
IWO · iShares Trust 0,52% 2.269.828 SH 11 de Setembro de 2026 Diário
JSMD · Janus Detroit Street Trust 0,51% 171.181 NS 31 de Julho de 2026 N-PORT
VTWG · VANGUARD SCOTTSDALE FUNDS 0,40% 258.034 SH 19 de Agosto de 2026 Diário
DWAS · Invesco Exchange-Traded Fund Trust … 0,36% 48.469 SH 2 de Outubro de 2026 Diário
FYX · First Trust Exchange-Traded AlphaDE… 0,35% 152.933 NS 31 de Julho de 2026 N-PORT
BKSE · BNY Mellon ETF Trust 0,31% 8.798 NS 31 de Julho de 2026 N-PORT
BBSC · J.P. Morgan Exchange-Traded Fund Tr… 0,27% 61.099 NS 31 de Julho de 2026 N-PORT
FYEE · Fidelity Greenwood Street Trust 0,27% 19.102 NS 31 de Julho de 2026 N-PORT
IWM · iShares Trust 0,26% 6.175.602 SH 11 de Setembro de 2026 Diário
FBUF · Fidelity Greenwood Street Trust 0,25% 1.889 NS 31 de Julho de 2026 N-PORT
ISCG · iShares Trust 0,24% 71.367 SH 11 de Setembro de 2026 Diário
RSSL · Global X Funds 0,24% 115.406 NS 31 de Julho de 2026 N-PORT
VTWO · VANGUARD SCOTTSDALE FUNDS 0,21% 1.387.125 SH 19 de Agosto de 2026 Diário
FHEQ · Fidelity Greenwood Street Trust 0,21% 61.010 NS 31 de Julho de 2026 N-PORT
VBK · VANGUARD INDEX FUNDS 0,19% 3.171.535 SH 19 de Agosto de 2026 Diário
DFAS · Dimensional ETF Trust 0,16% 805.292 NS 31 de Julho de 2026 N-PORT
PRFZ · Invesco Exchange-Traded Fund Trust 0,16% 145.781 SH 2 de Outubro de 2026 Diário
FAD · First Trust Exchange-Traded AlphaDE… 0,15% 27.872 NS 31 de Julho de 2026 N-PORT
ESML · iShares Trust 0,11% 96.895 SH 11 de Setembro de 2026 Diário
FNCL · FIDELITY COVINGTON TRUST 0,08% 61.975 NS 31 de Julho de 2026 N-PORT
VB · VANGUARD INDEX FUNDS 0,08% 5.488.922 SH 19 de Agosto de 2026 Diário
VFH · VANGUARD WORLD FUND 0,08% 384.466 SH 19 de Agosto de 2026 Diário
WSML · iShares Trust 0,07% 14.630 SH 11 de Setembro de 2026 Diário
VXF · VANGUARD INDEX FUNDS 0,07% 2.534.194 SH 19 de Agosto de 2026 Diário
IUS · Invesco Exchange-Traded Self-Indexe… 0,04% 12.495 SH 2 de Outubro de 2026 Diário
DFSU · Dimensional ETF Trust 0,03% 20.892 NS 31 de Julho de 2026 N-PORT
DCOR · Dimensional ETF Trust 0,02% 21.472 NS 31 de Julho de 2026 N-PORT
DFAC · Dimensional ETF Trust 0,02% 286.808 NS 31 de Julho de 2026 N-PORT
TILT · FlexShares Trust 0,02% 12.166 NS 31 de Julho de 2026 N-PORT
DFAU · Dimensional ETF Trust 0,01% 50.403 NS 31 de Julho de 2026 N-PORT
IWV · iShares Trust 0,01% 64.590 SH 11 de Setembro de 2026 Diário
VTI · VANGUARD INDEX FUNDS 0,01% 7.601.113 SH 19 de Agosto de 2026 Diário
VT · VANGUARD INTERNATIONAL EQUITY INDEX… 0,01% 194.738 SH 19 de Agosto de 2026 Diário
VTHR · VANGUARD SCOTTSDALE FUNDS 0,01% 19.808 SH 19 de Agosto de 2026 Diário
DFUS · Dimensional ETF Trust 0,01% 66.708 NS 31 de Julho de 2026 N-PORT
ESGV · VANGUARD WORLD FUND 0,01% 53.203 SH 19 de Agosto de 2026 Diário
ITOT · iShares Trust 0,01% 287.602 SH 11 de Setembro de 2026 Diário
DXUV · Dimensional ETF Trust 0,00% 472 NS 31 de Julho de 2026 N-PORT
IAK · iShares Trust · 117.671 SH 11 de Setembro de 2026 Diário
ISCB · iShares Trust · 10.063 SH 11 de Setembro de 2026 Diário
SMLF · iShares Trust · 286.871 SH 11 de Setembro de 2026 Diário

OSCR Consenso dos analistas Opiniões de analistas otimistas e pessimistas, preço-alvo de 12 meses, potencial de alta

21
classificação · 19 analistas COMPRA
Alvo mediano $33.50 +8,3%
2 10,5% Compra forte
7 36,8% Compra
9 47,4% Manter
1 5,3% Venda
0 0,0% Venda forte

Preço-alvo de 12 meses

10 analistas · 2026-10-03

Alvo médio $35.40 +14,4%

Agora Preço atual $30.94
Mín$26.00 Média$35.40 Máx$49.00

Comparação de pares (subindústria GICS) Métricas chave vs pares do setor

22

Base do ano fiscal, preços no fechamento do último ano fiscal de cada empresa.

Ticker Capitalização de Mercado P/E Receita YoY Margem Líquida ROE Margem Bruta
OSCR · -8.5 27.5% -3.8% -44.5% ·
AFL $57.20B 16.2 -9.3% 21.2% 12.9% ·
PRU · · · · · ·
PFG $19.18B 16.8 -3.1% 7.6% 10.3% ·
UNM · · · · · ·
GL $12.90B 9.9 3.7% 19.4% 20.4% ·
PRI $8.22B 11.3 6.6% 22.8% 31.9% ·
LNC $8.46B 7.6 -1.2% 6.5% 12.3% ·
CNO $4.01B 18.5 0.85% 5.1% 8.9% ·

Últimas notícias Notícias recentes mencionando esta empresa

23

Minhas Métricas Sua lista pessoal — linhas selecionadas de Fundamentos Completos

26

Escolha as métricas que importam para si — clique no + ao lado de qualquer linha em Fundamentos Completos acima.

Sua seleção é salva e acompanha você em todos os tickers.

Fonte: SEC 10-Q arquivado Ago 7, 2026